Nu Skin Enterprises (NYSE:NUS - Get Free Report) announced its earnings results on Thursday. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.14, Zacks reports. The company had revenue of $445.55 million during the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. Nu Skin Enterprises updated its Q1 2025 guidance to 0.100-0.200 EPS and its FY 2025 guidance to 0.900-1.300 EPS.
Nu Skin Enterprises Stock Performance
Shares of NYSE NUS traded up $1.12 during midday trading on Monday, reaching $7.54. The company had a trading volume of 3,578,441 shares, compared to its average volume of 494,146. The business's 50-day simple moving average is $6.88 and its 200 day simple moving average is $7.39. The stock has a market cap of $374.57 million, a P/E ratio of -3.64 and a beta of 1.17. Nu Skin Enterprises has a 1 year low of $5.95 and a 1 year high of $14.64. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53.
Nu Skin Enterprises Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th will be issued a $0.06 dividend. The ex-dividend date is Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.19%. Nu Skin Enterprises's dividend payout ratio is currently -8.14%.
Analysts Set New Price Targets
Several equities research analysts have weighed in on NUS shares. Citigroup lowered their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating for the company in a research note on Tuesday, October 22nd. DA Davidson lowered their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a research note on Friday, December 20th. Finally, StockNews.com cut shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Monday.
Get Our Latest Research Report on NUS
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Stories
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
